A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest
PHASE3CompletedINTERVENTIONAL
Enrollment
127
Participants
Timeline
Start Date
October 31, 1996
Study Completion Date
August 31, 1997
Conditions
Heart Failure, CongestiveHeart Decompensation
Interventions
DRUG
nesiritide
All Listed Sponsors
lead
Scios, Inc.
INDUSTRY
NCT00288730 - A Study of Two Doses of Intravenous NATRECOR hBNP (Nesiritide) in Patients With Worsening Congestive Heart Failure Who Have Difficulty Breathing at Rest | Biotech Hunter | Biotech Hunter